{"id":7323,"date":"2014-10-27T17:35:16","date_gmt":"2014-10-27T17:35:16","guid":{"rendered":"https:\/\/www.nicox.com\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/"},"modified":"2014-10-27T17:35:16","modified_gmt":"2014-10-27T17:35:16","slug":"nicox-finalise-lacquisition-daciex-therapeutics-inc","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/","title":{"rendered":"Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc."},"content":{"rendered":"<div>Sophia Antipolis, France.<\/div>\n<div>\u00a0<\/div>\n<div><strong>Nicox S.A.<\/strong> (NYSE Euronext Paris : COX) annonce aujourd\u2019hui la r\u00e9alisation d\u00e9finitive de l\u2019acquisition d\u2019Aciex Therapeutics, Inc., une soci\u00e9t\u00e9 pharmaceutique am\u00e9ricaine de d\u00e9veloppement en ophtalmologie, \u00e0 capitaux priv\u00e9s. Cette acquisition constitue une \u00e9tape majeure dans la strat\u00e9gie de Nicox visant \u00e0 cr\u00e9er une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie et permet d\u2019\u00e9largir et de renforcer de fa\u00e7on significative le portefeuille de m\u00e9dicaments en d\u00e9veloppement de Nicox.\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>Pour plus d\u2019informations, veuillez consulter :<\/div>\n<div>\u00a0<\/div>\n<ul>\n<li>Le communiqu\u00e9 de presse du 2 juillet 2014 : <a class=\"pyro-file\" href=\"https:\/\/www.nicox.com\/assets\/files\/pr2014070200fr.pdf\">Nicox : projet d\u2019acquisition d\u2019Aciex Therapeutics, Inc. \u00a0<\/a><\/li>\n<li>Le communiqu\u00e9 de presse du 22 octobre 2014 :\u00a0<a class=\"pyro-file\" href=\"https:\/\/www.nicox.com\/assets\/files\/pr2014102200FR11.pdf\">Approbation de l\u2019acquisition d\u2019Aciex Therapeutics, Inc. par les actionnaires de Nicox<\/a><\/li>\n<li>Le \u00ab\u00a0<a class=\"pyro-file\" href=\"https:\/\/www.nicox.com\/assets\/files\/1-amber-document-e-avec-n-enregistrement1.pdf\">Document E<\/a>\u00a0\u00bb enregistr\u00e9 aupr\u00e8s de l\u2019AMF le 30 septembre 2014 sous le num\u00e9ro E.14-060 (disponible sur le site Internet de Nicox <a href=\"https:\/\/www.nicox.com\">www.nicox.com<\/a>, rubrique Espace Investisseurs \/ Assembl\u00e9es G\u00e9n\u00e9rales).<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Sophia Antipolis, France. \u00a0 Nicox S.A. (NYSE Euronext Paris : COX) annonce aujourd\u2019hui la r\u00e9alisation d\u00e9finitive de l\u2019acquisition d\u2019Aciex Therapeutics, Inc., une soci\u00e9t\u00e9 pharmaceutique am\u00e9ricaine de d\u00e9veloppement en ophtalmologie, \u00e0 capitaux priv\u00e9s. Cette acquisition constitue une \u00e9tape majeure dans la strat\u00e9gie de Nicox visant \u00e0 cr\u00e9er une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie et permet d\u2019\u00e9largir [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-7323","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc. - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc. - Nicox\" \/>\n<meta property=\"og:description\" content=\"Sophia Antipolis, France. \u00a0 Nicox S.A. (NYSE Euronext Paris : COX) annonce aujourd\u2019hui la r\u00e9alisation d\u00e9finitive de l\u2019acquisition d\u2019Aciex Therapeutics, Inc., une soci\u00e9t\u00e9 pharmaceutique am\u00e9ricaine de d\u00e9veloppement en ophtalmologie, \u00e0 capitaux priv\u00e9s. Cette acquisition constitue une \u00e9tape majeure dans la strat\u00e9gie de Nicox visant \u00e0 cr\u00e9er une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie et permet d\u2019\u00e9largir [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-27T17:35:16+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-finalise-lacquisition-daciex-therapeutics-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-finalise-lacquisition-daciex-therapeutics-inc\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc.\",\"datePublished\":\"2014-10-27T17:35:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-finalise-lacquisition-daciex-therapeutics-inc\\\/\"},\"wordCount\":166,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-finalise-lacquisition-daciex-therapeutics-inc\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-finalise-lacquisition-daciex-therapeutics-inc\\\/\",\"name\":\"Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc. - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"2014-10-27T17:35:16+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-finalise-lacquisition-daciex-therapeutics-inc\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc. - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc. - Nicox","og_description":"Sophia Antipolis, France. \u00a0 Nicox S.A. (NYSE Euronext Paris : COX) annonce aujourd\u2019hui la r\u00e9alisation d\u00e9finitive de l\u2019acquisition d\u2019Aciex Therapeutics, Inc., une soci\u00e9t\u00e9 pharmaceutique am\u00e9ricaine de d\u00e9veloppement en ophtalmologie, \u00e0 capitaux priv\u00e9s. Cette acquisition constitue une \u00e9tape majeure dans la strat\u00e9gie de Nicox visant \u00e0 cr\u00e9er une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie et permet d\u2019\u00e9largir [&hellip;]","og_url":"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/","og_site_name":"Nicox","article_published_time":"2014-10-27T17:35:16+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/"},"author":{"name":"","@id":""},"headline":"Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc.","datePublished":"2014-10-27T17:35:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/"},"wordCount":166,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/","url":"https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/","name":"Nicox finalise l\u2019acquisition d\u2019Aciex Therapeutics, Inc. - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"2014-10-27T17:35:16+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/nicox-finalise-lacquisition-daciex-therapeutics-inc\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=7323"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/7323\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=7323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=7323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=7323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}